The right moves to rein in fibrosis
Biomedical researchers at Washington University have decoded how mechanical forces drive cell behavior in fibrosis.
Boosting brain’s waste removal system improves memory in old mice
Researchers at WashU Medicine have found a way to target the vessels that drain waste from the brain. Rejuvenating those vessels could open the door to new therapies to prevent cognitive decline.
Decades-long quest leads to new antibiotic compounds
A multidisciplinary team led by WashU chemists repurposed an antimalarial drug in the fight against antibiotic resistance.
Anti-amyloid drug shows signs of preventing Alzheimer’s dementia
A clinical trial among people destined to develop early-onset Alzheimer’s disease and led by WashU Medicine researchers shows eliminating amyloid from the brain may prevent cognitive symptoms.
¿Te puedo contar algo?
“¿Te puedo contar algo?”, an evening-length concert featuring new and original works by MFA candidates Tess Angelica Losada-Tindall and Lourdes del Mar Santiago Lebrón in Arts & Sciences, will explore the nature, power and necessity of grief March 21 and 22 in WashU’s Edison Theatre.
Board of Trustees ad hoc committee on spring 2024 protests completes report
The ad hoc committee established by the WashU Board of Trustees to review the university’s policies and guidelines governing on-campus protests and demonstrations has completed its work.
Exposing ‘forever chemicals’: Rob Bilott brings his fight to WashU
Rob Bilott, the attorney who exposed DuPont’s water contamination cover-up, will speak April 7 for the Assembly Series. “Dark Waters,” a film based on his fight for justice, screens in advance.
Researchers find missing link in autoimmune disorder
Scientists at WashU Medicine have identified a key component to launching immune activity and overactivity, providing a potential therapeutic target for autoimmune diseases.
A closer look at biomolecular ‘Silly Putty’
Researchers at Washington University have developed a method to peer into biomolecular condensates, which could lead to a better understanding of condensate functions and their impairment in cancers and neurodegeneration.
What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry
After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore — a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Olin Business School experts Patrick Aguilar and Peter Boumgarden.
View More Stories